UniProt ID | RCN1_HUMAN | |
---|---|---|
UniProt AC | Q15293 | |
Protein Name | Reticulocalbin-1 | |
Gene Name | RCN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 331 | |
Subcellular Localization | Endoplasmic reticulum lumen. | |
Protein Description | May regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-ER compartment.. | |
Protein Sequence | MARGGRGRRLGLALGLLLALVLAPRVLRAKPTVRKERVVRPDSELGERPPEDNQSFQYDHEAFLGKEDSKTFDQLTPDESKERLGKIVDRIDNDGDGFVTTEELKTWIKRVQKRYIFDNVAKVWKDYDRDKDDKISWEEYKQATYGYYLGNPAEFHDSSDHHTFKKMLPRDERRFKAADLNGDLTATREEFTAFLHPEEFEHMKEIVVLETLEDIDKNGDGFVDQDEYIADMFSHEENGPEPDWVLSEREQFNEFRDLNKDGKLDKDEIRHWILPQDYDHAQAEARHLVYESDKNKDEKLTKEEILENWNMFVGSQATNYGEDLTKNHDEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
43 | Phosphorylation | ERVVRPDSELGERPP HHEECCCCCCCCCCC | 37.09 | 29457462 | |
53 | N-linked_Glycosylation | GERPPEDNQSFQYDH CCCCCCCCCCCCCCH | 37.42 | 19159218 | |
54 | Ubiquitination | ERPPEDNQSFQYDHE CCCCCCCCCCCCCHH | 58.92 | - | |
55 | Phosphorylation | RPPEDNQSFQYDHEA CCCCCCCCCCCCHHH | 22.14 | 25850435 | |
55 | O-linked_Glycosylation | RPPEDNQSFQYDHEA CCCCCCCCCCCCHHH | 22.14 | 30059200 | |
58 | Phosphorylation | EDNQSFQYDHEAFLG CCCCCCCCCHHHHCC | 19.77 | 25850435 | |
69 | Phosphorylation | AFLGKEDSKTFDQLT HHCCCCCCCCHHHCC | 34.39 | 23312004 | |
70 | Ubiquitination | FLGKEDSKTFDQLTP HCCCCCCCCHHHCCC | 66.58 | 21890473 | |
70 | 2-Hydroxyisobutyrylation | FLGKEDSKTFDQLTP HCCCCCCCCHHHCCC | 66.58 | - | |
70 | Acetylation | FLGKEDSKTFDQLTP HCCCCCCCCHHHCCC | 66.58 | 27452117 | |
70 | Ubiquitination | FLGKEDSKTFDQLTP HCCCCCCCCHHHCCC | 66.58 | 21890473 | |
71 | Ubiquitination | LGKEDSKTFDQLTPD CCCCCCCCHHHCCCC | 36.07 | - | |
71 | Phosphorylation | LGKEDSKTFDQLTPD CCCCCCCCHHHCCCC | 36.07 | 25159151 | |
76 | Phosphorylation | SKTFDQLTPDESKER CCCHHHCCCCHHHHH | 24.06 | 20068231 | |
80 | Phosphorylation | DQLTPDESKERLGKI HHCCCCHHHHHHHHH | 47.39 | 29255136 | |
81 | Sumoylation | QLTPDESKERLGKIV HCCCCHHHHHHHHHH | 44.82 | - | |
81 | 2-Hydroxyisobutyrylation | QLTPDESKERLGKIV HCCCCHHHHHHHHHH | 44.82 | - | |
81 | Acetylation | QLTPDESKERLGKIV HCCCCHHHHHHHHHH | 44.82 | 23236377 | |
81 | Methylation | QLTPDESKERLGKIV HCCCCHHHHHHHHHH | 44.82 | - | |
83 | Methylation | TPDESKERLGKIVDR CCCHHHHHHHHHHHH | 53.10 | 24411213 | |
86 | Ubiquitination | ESKERLGKIVDRIDN HHHHHHHHHHHHHCC | 44.12 | 21890473 | |
86 | Acetylation | ESKERLGKIVDRIDN HHHHHHHHHHHHHCC | 44.12 | 19608861 | |
86 | Ubiquitination | ESKERLGKIVDRIDN HHHHHHHHHHHHHCC | 44.12 | 21890473 | |
90 | Ubiquitination | RLGKIVDRIDNDGDG HHHHHHHHHCCCCCC | 27.54 | - | |
90 | Methylation | RLGKIVDRIDNDGDG HHHHHHHHHCCCCCC | 27.54 | 115490981 | |
100 | Phosphorylation | NDGDGFVTTEELKTW CCCCCCEEHHHHHHH | 26.65 | - | |
101 | Phosphorylation | DGDGFVTTEELKTWI CCCCCEEHHHHHHHH | 23.35 | - | |
105 | Ubiquitination | FVTTEELKTWIKRVQ CEEHHHHHHHHHHHH | 45.13 | 21890473 | |
105 | Ubiquitination | FVTTEELKTWIKRVQ CEEHHHHHHHHHHHH | 45.13 | 21890473 | |
114 | Ubiquitination | WIKRVQKRYIFDNVA HHHHHHHHHHHHHHH | 16.82 | - | |
114 | Methylation | WIKRVQKRYIFDNVA HHHHHHHHHHHHHHH | 16.82 | 115490993 | |
115 | Phosphorylation | IKRVQKRYIFDNVAK HHHHHHHHHHHHHHH | 16.99 | 28152594 | |
122 | 2-Hydroxyisobutyrylation | YIFDNVAKVWKDYDR HHHHHHHHHHHHCCC | 44.33 | - | |
122 | Ubiquitination | YIFDNVAKVWKDYDR HHHHHHHHHHHHCCC | 44.33 | 21890473 | |
122 | Ubiquitination | YIFDNVAKVWKDYDR HHHHHHHHHHHHCCC | 44.33 | 21890473 | |
125 | 2-Hydroxyisobutyrylation | DNVAKVWKDYDRDKD HHHHHHHHHCCCCCC | 49.77 | - | |
125 | Ubiquitination | DNVAKVWKDYDRDKD HHHHHHHHHCCCCCC | 49.77 | - | |
134 | 2-Hydroxyisobutyrylation | YDRDKDDKISWEEYK CCCCCCCCCCHHHHH | 49.09 | - | |
134 | Acetylation | YDRDKDDKISWEEYK CCCCCCCCCCHHHHH | 49.09 | 26051181 | |
134 | Ubiquitination | YDRDKDDKISWEEYK CCCCCCCCCCHHHHH | 49.09 | - | |
136 | Phosphorylation | RDKDDKISWEEYKQA CCCCCCCCHHHHHHH | 33.89 | 25159151 | |
141 | Ubiquitination | KISWEEYKQATYGYY CCCHHHHHHHHCCCC | 36.41 | 21890473 | |
141 | Ubiquitination | KISWEEYKQATYGYY CCCHHHHHHHHCCCC | 36.41 | 21890473 | |
145 | Phosphorylation | EEYKQATYGYYLGNP HHHHHHHCCCCCCCH | 13.22 | 25884760 | |
147 | Phosphorylation | YKQATYGYYLGNPAE HHHHHCCCCCCCHHH | 5.77 | - | |
158 | Phosphorylation | NPAEFHDSSDHHTFK CHHHCCCCCCCHHHH | 29.15 | 25627689 | |
159 | Phosphorylation | PAEFHDSSDHHTFKK HHHCCCCCCCHHHHH | 47.20 | 25627689 | |
165 | 2-Hydroxyisobutyrylation | SSDHHTFKKMLPRDE CCCCHHHHHHCCCCH | 38.13 | - | |
165 | Ubiquitination | SSDHHTFKKMLPRDE CCCCHHHHHHCCCCH | 38.13 | 21890473 | |
165 | Acetylation | SSDHHTFKKMLPRDE CCCCHHHHHHCCCCH | 38.13 | 26051181 | |
165 | Ubiquitination | SSDHHTFKKMLPRDE CCCCHHHHHHCCCCH | 38.13 | 21890473 | |
166 | Acetylation | SDHHTFKKMLPRDER CCCHHHHHHCCCCHH | 41.29 | 156545 | |
176 | Ubiquitination | PRDERRFKAADLNGD CCCHHHHHHHHCCCC | 40.63 | 21890473 | |
176 | Ubiquitination | PRDERRFKAADLNGD CCCHHHHHHHHCCCC | 40.63 | 21890473 | |
176 | 2-Hydroxyisobutyrylation | PRDERRFKAADLNGD CCCHHHHHHHHCCCC | 40.63 | - | |
185 | Phosphorylation | ADLNGDLTATREEFT HHCCCCCCEEHHHHH | 30.62 | 25159151 | |
187 | Phosphorylation | LNGDLTATREEFTAF CCCCCCEEHHHHHHH | 33.12 | 21406692 | |
192 | Phosphorylation | TATREEFTAFLHPEE CEEHHHHHHHCCHHH | 21.56 | 25022875 | |
192 | O-linked_Glycosylation | TATREEFTAFLHPEE CEEHHHHHHHCCHHH | 21.56 | OGP | |
203 | Sulfoxidation | HPEEFEHMKEIVVLE CHHHHHHHHEEEEEE | 3.07 | 30846556 | |
211 | Phosphorylation | KEIVVLETLEDIDKN HEEEEEEEHHHHHHC | 31.14 | 23663014 | |
228 | Phosphorylation | GFVDQDEYIADMFSH CCCCHHHHHHHHHCC | 15.08 | 28102081 | |
234 | Phosphorylation | EYIADMFSHEENGPE HHHHHHHCCCCCCCC | 24.29 | 20071362 | |
249 | Methylation | PDWVLSEREQFNEFR CCCCCCHHHHHHHHH | 39.37 | 115490987 | |
263 | 2-Hydroxyisobutyrylation | RDLNKDGKLDKDEIR HHCCCCCCCCHHHHH | 64.74 | - | |
266 | Acetylation | NKDGKLDKDEIRHWI CCCCCCCHHHHHHHH | 68.63 | 26051181 | |
266 | 2-Hydroxyisobutyrylation | NKDGKLDKDEIRHWI CCCCCCCHHHHHHHH | 68.63 | - | |
270 | Methylation | KLDKDEIRHWILPQD CCCHHHHHHHHCCCC | 19.62 | 115490969 | |
278 | Phosphorylation | HWILPQDYDHAQAEA HHHCCCCCCHHHHHH | 12.37 | 27642862 | |
286 | Methylation | DHAQAEARHLVYESD CHHHHHHHHHHHHCC | 18.38 | 115490975 | |
290 | Phosphorylation | AEARHLVYESDKNKD HHHHHHHHHCCCCCC | 18.97 | 28152594 | |
292 | Phosphorylation | ARHLVYESDKNKDEK HHHHHHHCCCCCCCC | 35.88 | 28152594 | |
294 | Ubiquitination | HLVYESDKNKDEKLT HHHHHCCCCCCCCCC | 75.16 | - | |
294 | 2-Hydroxyisobutyrylation | HLVYESDKNKDEKLT HHHHHCCCCCCCCCC | 75.16 | - | |
296 | 2-Hydroxyisobutyrylation | VYESDKNKDEKLTKE HHHCCCCCCCCCCHH | 73.36 | - | |
299 | 2-Hydroxyisobutyrylation | SDKNKDEKLTKEEIL CCCCCCCCCCHHHHH | 72.14 | - | |
311 | Sulfoxidation | EILENWNMFVGSQAT HHHHHHHHHCCHHHH | 1.86 | 30846556 | |
315 | Phosphorylation | NWNMFVGSQATNYGE HHHHHCCHHHHCCCC | 16.02 | 23663014 | |
315 | O-linked_Glycosylation | NWNMFVGSQATNYGE HHHHHCCHHHHCCCC | 16.02 | OGP | |
318 | Phosphorylation | MFVGSQATNYGEDLT HHCCHHHHCCCCCCC | 22.72 | 23663014 | |
320 | Phosphorylation | VGSQATNYGEDLTKN CCHHHHCCCCCCCCC | 19.96 | 23663014 | |
325 | Phosphorylation | TNYGEDLTKNHDEL- HCCCCCCCCCCCCC- | 41.96 | 23663014 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
80 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RCN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RCN1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-86, AND MASS SPECTROMETRY. | |
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53, AND MASS SPECTROMETRY. |